2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Cancer Metabolomics
Metabolomics is the worldwide assessment and confirmation of endogenous small-molecule biochemicals (metabolites) within a biologic system. It is one of the "omic" sciences in systems biology. The metabolism of cancer cells is dysregulated to meet the demands of uncontrolled proliferation. This rewiring of cellular metabolism produces distinct metabolic phenotypes that can be exploited for earlier cancer detection, patient selection techniques for clinical trials, and/or treatment response biomarkers. Metabolomics aims to use cancer’s metabolic signature to estimate disease risk, detect cancer earlier, diagnose particular disease subtypes, and track treatment outcomes. In principle, metabolomics could aid in the rational selection of targeted medicines to meet cancer’s metabolic requirements.
- Cancer Cell Metabolism
- Cancer Therapies That Target Metabolism
- Systemic Metabolic Effects of Cancer
- Clinical Implementation of Metabolomics
- Biomarkers for Cancer
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Liu Ying
Shanghai University, China
Ratan Kumar Sarkar
Independent Researcher, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India